Prophecy Emergency Department Registered Nurse (RN) Practice Test

The selection of Phenobarbital as the anticipated medication for a six-month-old experiencing an active tonic-clonic seizure is based on its historical use and effectiveness in managing seizures in infants and young children. Phenobarbital is a barbiturate that acts as an anticonvulsant and is often preferred for its ability to control seizures effectively in pediatric patients.

In the context of an active seizure, the immediate goal is to halt the seizure activity and provide rapid stabilization of the patient. Phenobarbital can be given intravenously, offering a quick route for achieving therapeutic drug levels in an emergency setting. It also has a long-standing track record in pediatric settings, making it a commonly used agent for this age group.

Other medications such as Valproic acid and Phenytoin are not typically the first line for very young children due to age restrictions and potential side effects. Lacosamide, while effective as an anticonvulsant, is less commonly used in infants and has limited safety data in this age group. Thus, Phenobarbital remains the most suitable and established choice for managing tonic-clonic seizures in young infants.